✦ LIBER ✦

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

✍ Scribed by Aerts, J. G.; Codrington, H.; Lankheet, N. A. G.; Burgers, S.; Biesma, B.; Dingemans, A. - M. C.; Vincent, A. D.; Dalesio, O.; Groen, H. J. M.; Smit, E. F.

Book ID: 121340461
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 315 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of gefitinib v

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

✍ Kim, Seung Tae; Uhm, Ji Eun; Lee, Jeeyun; Sun, Jong-mu; Sohn, Insuk; Kim, Seon W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Randomized Phase II Study of Erlotinib P

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer

✍ Sequist, L. V.; von Pawel, J.; Garmey, E. G.; Akerley, W. L.; Brugger, W.; Ferra 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Sorafenib in combination with erlotinib

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

✍ Gridelli, C.; Morgillo, F.; Favaretto, A.; de Marinis, F.; Chella, A.; Cerea, G. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 125 KB

Pemetrexed versus erlotinib in pretreate

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

✍ Karampeazis, Athanasios; Voutsina, Alexandra; Souglakos, John; Kentepozidis, Nik 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Randomized phase 2 study of the cyclin-d

Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer

✍ Stephenson, Joe J.; Nemunaitis, John; Joy, Anil A.; Martin, Julie C.; Jou, Ying- 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 579 KB

Randomized open-label non-comparative mu

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

✍ Auliac, J.B.; Chouaid, C.; Greiller, L.; Monnet, I.; Le Caer, H.; Falchero, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 484 KB